In the case of common VEGFA polymorphisms, most patients were heterozygous AC for rs699947 (49% of non-NPC and 46% of NPC patients), heterozygous for the rs144854329 18 bp indel (49% of non-NPC and 53.6% of NPC), heterozygous for the 1 bp insertion rs35864111 (49% of non-NPC and 53.6% of NPC) and heterozygous CT for rs833061 (referred to as −1498 herein) (50.3% for non-NPC and 48.8% for NPC). Here, VEGFA is linked to nasopharyngeal carcinoma.